GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AddLife AB (OSTO:ALIF B) » Definitions » Cyclically Adjusted PS Ratio

AddLife AB (OSTO:ALIF B) Cyclically Adjusted PS Ratio : 3.40 (As of Jul. 02, 2025)


View and export this data going back to 2016. Start your Free Trial

What is AddLife AB Cyclically Adjusted PS Ratio?

As of today (2025-07-02), AddLife AB's current share price is kr187.50. AddLife AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was kr55.19. AddLife AB's Cyclically Adjusted PS Ratio for today is 3.40.

The historical rank and industry rank for AddLife AB's Cyclically Adjusted PS Ratio or its related term are showing as below:

OSTO:ALIF B' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.97   Med: 2.79   Max: 3.6
Current: 3.42

During the past years, AddLife AB's highest Cyclically Adjusted PS Ratio was 3.60. The lowest was 1.97. And the median was 2.79.

OSTO:ALIF B's Cyclically Adjusted PS Ratio is ranked worse than
60.87% of 483 companies
in the Medical Devices & Instruments industry
Industry Median: 2.24 vs OSTO:ALIF B: 3.42

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

AddLife AB's adjusted revenue per share data for the three months ended in Mar. 2025 was kr22.172. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is kr55.19 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


AddLife AB Cyclically Adjusted PS Ratio Historical Data

The historical data trend for AddLife AB's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AddLife AB Cyclically Adjusted PS Ratio Chart

AddLife AB Annual Data
Trend Mar15 Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 2.57

AddLife AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.25 2.47 3.16 2.57 2.63

Competitive Comparison of AddLife AB's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, AddLife AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AddLife AB's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AddLife AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where AddLife AB's Cyclically Adjusted PS Ratio falls into.


;
;

AddLife AB Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

AddLife AB's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=187.50/55.19
=3.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AddLife AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, AddLife AB's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=22.172/132.8245*132.8245
=22.172

Current CPI (Mar. 2025) = 132.8245.

AddLife AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 3.999 99.995 5.312
201509 4.477 100.228 5.933
201512 5.704 100.276 7.555
201603 4.991 100.751 6.580
201606 4.791 101.019 6.299
201609 3.958 101.138 5.198
201612 5.967 102.022 7.769
201703 5.620 102.022 7.317
201706 5.581 102.752 7.214
201709 5.054 103.279 6.500
201712 6.545 103.793 8.376
201803 5.880 103.962 7.512
201806 6.127 104.875 7.760
201809 5.725 105.679 7.196
201812 6.951 105.912 8.717
201903 7.920 105.886 9.935
201906 7.477 106.742 9.304
201909 7.132 107.214 8.836
201912 8.805 107.766 10.852
202003 9.351 106.563 11.655
202006 11.117 107.498 13.736
202009 11.058 107.635 13.646
202012 15.083 108.296 18.499
202103 15.363 108.360 18.832
202106 18.774 108.928 22.893
202109 15.171 110.338 18.263
202112 17.193 112.486 20.302
202203 21.174 114.825 24.493
202206 17.082 118.384 19.166
202209 17.150 122.296 18.626
202212 18.658 126.365 19.612
202303 20.051 127.042 20.964
202306 19.408 129.407 19.921
202309 19.031 130.224 19.411
202312 20.877 131.912 21.021
202403 21.090 132.205 21.189
202406 20.958 132.716 20.975
202409 19.235 132.304 19.311
202412 23.124 132.987 23.096
202503 22.172 132.825 22.172

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


AddLife AB  (OSTO:ALIF B) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


AddLife AB Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of AddLife AB's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AddLife AB Business Description

Traded in Other Exchanges
Address
Brunkebergstorg 5, Box 3145, Stockholm, SWE, 103 62
AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in two segments: Labtech and Medtech segments. The Labtech segment, which accounts for the majority of the company revenue, provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service. The Medtech segment includes products related to surgery, thoracic medicine, neurology, wound care, anesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare. AddLife mainly caters to hospitals and laboratories within healthcare, research, colleges, and universities, as well as the food and pharmaceutical industries. Its geographical segments are Sweden, Denmark, Finland, Norway, and Other countries.

AddLife AB Headlines

No Headlines